Dichloroacetate (DCA) in Patients With Previously Treated Metastatic Breast or Non-Small Cell Lung Cancer (NSCL)
Status:
Terminated
Trial end date:
2011-11-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine the response rate by RECIST criteria of oral
dichloroacetate in patients with recurrent and/or metastatic and pretreated breast and
non-small cell lung cancer.